Skip to main content
logo
Verastem, Inc. (VSTM)
NASDAQ: VSTM · Real-Time Price · USD
5.55
+0.25 (4.72%)
At close: Apr 1, 2026, 4:00 PM EDT
5.57
+0.02 (0.27%)
Pre-market: Apr 2, 2026, 6:32 AM EDT

Verastem Revenue

In the year 2025, Verastem had annual revenue of $30.91M with 209.14% growth. Verastem had revenue of $17.54M in the quarter ending December 31, 2025.

Revenue (ttm)
$30.91M
Revenue Growth
+209.14%
P/S Ratio
15.77
Revenue / Employee
$303,078
Employees
102
Market Cap
487.48M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202530.91M20.91M209.14%
Dec 31, 202410.00M--
Dec 31, 2023---
Dec 31, 20222.60M543.00K26.45%
Dec 31, 20212.05M-86.46M-97.68%
Dec 31, 202088.52M71.06M407.08%
Dec 31, 201917.46M-9.26M-34.67%
Dec 31, 201826.72M--
Dec 31, 2017---
Dec 31, 2016---
Dec 31, 2015---
Dec 31, 2014---
Dec 31, 2013---
Dec 31, 2012---
Dec 31, 2011---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Fulcrum Therapeutics80.00M
Assembly Biosciences72.30M
Entrada Therapeutics25.42M
Absci2.80M
Shattuck Labs1.00M
Lyell Immunopharma36.00K
Revenue Rankings

VSTM News

More News